PRTC
NASDAQ
US
PureTech Health plc - American Depositary Shares
$15.52
▲ +$0.52
(+3.47%)
Vol 12K
8
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$302.1M
P/E
8.0
ROE
12.8%
Margin
792.9%
D/E
5.56
Beta
2.00
52W
$100–$158
Wall Street Consensus
5 analysts · Apr 20262
Strong Buy
2
Buy
1
Hold
0
Sell
0
Strong Sell
80.0%
Buy Rating
Price Chart
Similar Stocks
ORGO
Organogenesis Holdings Inc
P/E 654.1
$657.4M
NBP
NovaBridge Biosciences
$458.9M
AVXL
Anavex Life Sciences Corp
$318.1M
TARA
Protara Therapeutics Inc
$275.2M
CCCC
C4 Therapeutics Inc
$185.1M
ABEO
Abeona Therapeutics Inc
P/E 3.5
$285.6M
ALEC
Alector Inc
$170.3M
EDIT
Editas Medicine Inc
$200.1M
TLSI
TriSalus Life Sciences Inc
$348.8M
CHRS
Coherus Oncology Inc
P/E 1.1
$171.6M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2024 | $-0.20 | $-0.22 | $-0.02 |
| Jun 2024 | $-0.30 | $-0.21 | +$0.09 |
| Jun 2023 | $0.03 | $-0.32 | $-0.35 |
| Jun 2022 | $-0.20 | $-0.08 | +$0.12 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 12.8% | 14.6% | 14.6% | 12.8% | 12.8% | 12.8% |
| P/E (TTM) | 7.95 | 8.19 | 8.08 | 8.40 | 7.85 | 8.03 |
| Net Margin | -2409.8% | 1108.3% | 1108.3% | 792.9% | 792.9% | 792.9% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 5.56 | 5.39 | 5.39 | 5.56 | 5.56 | 5.56 |
| Current Ratio | 8.49 | 9.33 | 9.33 | 8.49 | 8.49 | 8.49 |
Key Ratios
ROA (TTM)
8.8%
P/S (TTM)
63.69
P/B
1.2
EPS (TTM)
$0.21
CF/Share
$-0.09
Rev Growth 3Y
-34.8%
52W High
$157.80
52W Low
$100.40
$100.40
52-Week Range
$157.80
How does PRTC compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PRTC valuation vs Biotechnology peers
P/E ratio
8.0
▼
57%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
63.7
▲
396%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.2
▼
53%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PRTC profitability vs Biotechnology peers
ROE
12.8%
▲
119%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
792.9%
▲
377%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
8.8%
▲
119%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
PRTC financial health vs Biotechnology peers
D/E ratio
5.6
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
8.5
▲
91%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.0
▲
106%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
PRTC fundamentals radar
PRTC
Peer median
Industry
PRTC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PRTC vs peers: key metrics
Latest News
No related news yet